Introduction: Vascular cognitive impairment (VCI) refers to the effects of cerebrovascular disease
(CVD) on cognition, from mild isolated deficits to dementia. VCI is the second most
common cause of cognitive impairment in the elderly, behind Alzheimer disease. Depression
is highly prevalent among patients with VCI, but little is known about its response
to treatment. The purpose of this study was to determine whether or not sertraline,
a commonly used antidepressant, would benefit patients with VCI and related depression.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of Geriatric PsychiatryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
